Drug Pipeline

RG002C0106 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07305974 A Phase IIa Clinical Study of RG002C0106 Injection in Subjects With Primary IgA… IgA Nephropathy (IgAN) Recruiting
Phase 1
NCT06494527 A Phase 1 Study to Evaluate the Safety/Tolerability, PK/PD of RG002C0106 Injection in… Safety Issues Active, Not Recruiting
NCT07445906 A Study of RG002C0106 Injection in Adult Participants With Normal Renal Function and… Renal Impairments Not Yet Recruiting
Sponsors Running RG002C0106 Trials
Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. (3)
Get alerts when RG002C0106 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free